Immunocore Holdings PLC (NAS:IMCR)
$ 31.85 0 (0%) Market Cap: 1.59 Bil Enterprise Value: 1.16 Bil PE Ratio: 0 PB Ratio: 4.28 GF Score: 66/100

Q2 2024 Immunocore Holdings PLC Earnings Call Transcript

Aug 08, 2024 / 12:00PM GMT
Release Date Price: $37.92 (+2.76%)
Operator

Welcome to the Immunocore conference call and webcast. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the call over to Clayton Robertson, Head of Investor Relations. Thank you. You may begin.

Clayton Robertson
Immunocore Holdings PLC - Head of Investor Relations

Good morning and good afternoon. Thank you for joining us on our Q2 and first-half 2024 for earnings call today. During today's call, we will make some forward-looking statements, which are qualified by the Safe Harbor provision under the Private Securities Litigation Reform Act of 1995. Please note that actual results can vary materially from those indicated by these forward-looking statements, including those discussed in our filings with the SEC.

On today's call, I'm joined by Bahija Jallal, CEO of Immunocore; and Brian Di Donato, CFO and Head of Strategy, who will share a strategy update. Ralph Torbay, Head of Commercial, will review our first half KIMMTRAK sales and additional growth opportunities for KIMMTRAK.

David Berman,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot